23andMe shares surge 17% in their trading debut after merger with Richard Branson-backed SPAC
June 17, 2021 at 14:14 PM EDT
Shares of consumer genetics company 23andMe rose about 17% in their trading debut Thursday, after the provider of home DNA test kits went public via a merger with Richard Branson's special-purpose acquisition corporation, or SPAC, VG Acquisition Corp.
